Emerging evidence indicates that MAPK4 regulation of the AKT signalling pathway may be involved in the pathogenesis of tumours, such as lung adenocarcinoma, colon cancer, and prostate cancer [18]. The gene discussed is AKT1; the disease is neoplasm.